Sudeshna Patra
Papers
1
Total Citations
12
H-Index
1
About
Dr. Sudeshna Patra is a leading ophthalmology researcher whose work focuses on developing innovative treatments for retinal diseases, particularly neovascular age-related macular degeneration (nAMD). Her most significant contribution is the pivotal STAR trial, a landmark randomized, double-masked, sham-controlled study evaluating stereotactic radiotherapy for nAMD. This groundbreaking work demonstrated that precisely targeted ionizing radiation can mitigate key pathogenic processes underlying the disease, potentially reducing the burden of frequent anti-VEGF injections that are the current standard of care. The STAR trial, published in 2024 and already garnering 12 citations, represents a paradigm-shifting approach to treating this leading cause of blindness. Dr. Patra’s research addresses the critical clinical challenge of treatment burden in nAMD, exploring how radiation therapy can complement or reduce dependence on intravitreal injections. Her work sits at the intersection of radiation oncology and ophthalmology, offering patients a potential alternative that could improve both visual outcomes and quality of life. Through this pioneering device trial, Dr. Patra has established herself as a key figure in the search for more durable, less invasive treatments for age-related macular degeneration.
Research Focus
Key Achievements
Top Papers
- 1